Chronic treatment with baicalin prevents the chronic mild stress-induced depressive-like behavior: Involving the inhibition of cyclooxygenase-2 in rat brain

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 40, Issue 1, 2013, Pages 138-143

  Li, Yu Cheng ^a   Shen, Ji Duo ^a   Li, Jing ^b   Wang, Rui ^b   Jiao, Shuo ^b   Yi, Li Tao ^b  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^b HUAQIAO UNIVERSITY   (China)

Author keywords

Antidepressant; Baicalin; Chronic mild stress (CMS); Cyclooxygenase 2 (COX 2); Prostaglandin E2 (PGE2)

Indexed keywords

BAICALIN; CORTICOSTERONE; CYCLOOXYGENASE 2; FLUOXETINE; MESSENGER RNA; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC MILD STRESS; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG DOSE COMPARISON; DRUG EFFICACY; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME INHIBITION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; CORTICOSTERONE; CYCLOOXYGENASE 2 INHIBITORS; DEPRESSION; DEPRESSIVE DISORDER; DINOPROSTONE; FLAVONOIDS; HINDLIMB SUSPENSION; MALE; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84867897745     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.09.007     Document Type: Article

References (57)

1. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004, 29:185-193.
2. Cao Y., Li G., Wang Y.F., Fan Z.K., Yu D.S., Wang Z.D., et al. Neuroprotective effect of baicalin on compression spinal cord injury in rats. Brain Res 2010, 1357:115-123.
3. Cassano P., Hidalgo A., Burgos V., Adris S., Argibay P. Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression). Pharmacogenomics J 2006, 6:381-387.
4. Cheng O., Li Z., Han Y., Jiang Q., Yan Y., Cheng K. Baicalin improved the spatial learning ability of global ischemia/reperfusion rats by reducing hippocampal apoptosis. Brain Res 2012, 10.1016/j.brainres.2012.06.026.
5. Cho K.H., Kang H.S., Jung W.S., Park S.U., Moon S.K. Efficacy and safety of chunghyul-dan (qingwie-dan) in patients with hypercholesterolemia. Am J Chin Med 2005, 33:241-248.
6. Dantzer R. Cytokine, sickness behavior, and depression. Neurol Clin 2006, 24:441-460.
7. Delgado P.L. Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000, 61:7-11.
8. Dhir A., Padi S.S., Naidu P.S., Kulkarni S.K. Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice. Eur J Pharmacol 2006, 535:192-198.
9. Edgar V.A., Cremaschi G.A., Sterin-Borda L., Genaro A.M. Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine. Brain Behav Immun 2002, 16:333-350.
10. First M., Gil-Ad I., Taler M., Tarasenko I., Novak N., Weizman A. The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. J Mol Neurosci 2011, 45:246-255.
11. Gamaro G.D., Prediger M.E., Lopes J., Bassani M.G., Dalmaz C. Fluoxetine alters feeding behavior and leptin levels in chronically-stressed rats. Pharmacol Biochem Behav 2008, 90:312-317.
12. Gárate I., García-Bueno B., Madrigal J.L., Bravo L., Berrocoso E., Caso J.R., et al. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation 2011, 8:151.
13. Ge Q.F., Hu X., Ma Z.Q., Liu J.R., Zhang W.P., Chen Z., et al. Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons. Pharmacol Res 2007, 55:148-157.
14. Gilroy D.W., Colville-Nash P.R. New insights into the role of COX 2 in inflammation. J Mol Med 2000, 78:121-129.
15. Gol'dberg V.E., Ryzhakov V.M., Matiash M.G., Stepovaia E.A., Boldyshev D.A., Litvinenko V.I., et al. Dry extract of Scutellaria baicalensis as a hemostimulant in antineoplastic chemotherapy in patents with lung cancer. Eksp Klin Farmakol 1997, 60:28-30.
16. Guo J.Y., Li C.Y., Ruan Y.P., Sun M., Qi X.L., Zhao B.S., et al. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol 2009, 612:54-60.
17. Hu F., Wang X., Pace T.W., Wu H., Miller A.H. Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function. Mol Psychiatry 2005, 10:426-428.
18. Johansson D., Falk A., Marcus M.M., Svensson T.H. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2012, 10.1016/j.pnpbp.2012.06.003.
19. Kaneko T., Chiba H., Horie N., Kato T., Kobayashi M., Hashimoto K., et al. Effect of Scutellariae radix ingredients on prostaglandin E(2) production and COX-2 expression by LPS-activated macrophage. In Vivo 2009, 23:577-581.
20. Kawasaki M., Yoshihara Y., Yamaji M., Watanabe Y. Expression of prostaglandin endoperoxide synthase in rat brain. Brain Res Mol Brain Res 1993, 19:39-46.
21. Kim S.J., Moon Y.J., Lee S.M. Protective effects of baicalin against ischemia/reperfusion injury in rat liver. J Nat Prod 2010, 73:2003-2008.
22. Koistinaho J., Chan P.H. Spreading depression-induced cyclooxygenase-2 expression in the frontal cortex. Neurochem Res 2000, 25:645-651.
23. Kubera M., Obuchowicz E., Goehler L., Brzeszcz J., Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:744-759.
24. Kumari B., Kumar A., Dhir A. Protective effect of non-selective and selective COX-2-inhibitors in acute immobilization stress-induced behavioral and biochemical alterations. Pharmacol Rep 2007, 59:699-707.
25. Kuwano T., Nakao S., Yamamoto H., Tsuneyoshi M., Yamamoto T., Kuwano M., et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 2004, 18:300-310.
26. Leonard B.E. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:767-780.
27. Leonard B.E. Stress, norepinephrine and depression. J Psychiatry Neurosci 2001, 26:S11-S16.
28. Li Y.C., Wang F.M., Pan Y., Qiang L.Q., Cheng G., Zhang W.Y., et al. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:435-449.
29. Li M., Tsang K.S., Choi S.T., Li K., Shaw P.C., Lau K.F. Neuronal differentiation of C17.2 neural stem cells induced by a natural flavonoid, baicalin. Chembiochem 2011, 12:449-456.
30. Li Y.C., Li H.B., Zhang B. Antidepressant effects of the total flavonoids of Scutellaria baicalensis in mice. Chin J Exp Tradit Med Form 2011, 17:161-163.
31. Li Y., Zhuang P., Shen B., Zhang Y., Shen J. Baicalin promotes neuronal differentiation of neural stem/progenitor cells through modulating p-stat3 and bHLH family protein expression. Brain Res 2012, 1429:36-42.
32. Li Y.C., Shen J.D., Liu Y.M., Yi L.T. Screening of antidepressant effects of four main flavonoids compounds from Scutellaria baicalensis. Chin J Exp Tradit Med Form 2012, 18:166-169.
33. Licinio J., Wong M.L. Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 1997, 100:2941-2947.
34. Liu W., Zhou C. Corticosterone reduces brain mitochondrial function and expression of mitofusin, BDNF in depression-like rodents regardless of exercise preconditioning. Psychoneuroendocrinology 2012, 37:1057-1070.
35. Liu Y.F., Gao F., Li X.W., Jia R.H., Meng X.D., Zhao R., et al. The anticonvulsant and neuroprotective effects of baicalin on pilocarpine-induced epileptic model in rats. Neurochem Res 2012, 37:1670-1680.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
37. Madrigal J.L., Moro M.A., Lizasoain I., Lorenzo P., Fernández A.P., Rodrigo J., et al. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 2003, 28:1579-1588.
38. Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999, 461:25-46.
39. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 2004, 63:901-910.
40. Mori K., Kondo T., Kamiyama Y., Kano Y., Tominaga K. Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 2003, 51:403-406.
41. Müller N., Schwarz M.J., Dehning S., Douhe A., Cerovecki A., Goldstein-Müller B., et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006, 11:680-684.
42. Nakayama M., Uchimura K., Zhu R.L., Nagayama T., Rose M.E., Stetler R.A., et al. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci U S A 1998, 95:10954-10959.
43. Nery F.G., Monkul E.S., Hatch J.P., Fonseca M., Zunta-Soares G.B., Frey B.N., et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol 2008, 23:87-94.
44. Nogawa S., Takao M., Suzuki S., Tanaka K., Koto A., Fukuuchi Y., et al. COX-2 expression in brains of patients with familial Alzheimer's disease. Int Congr 2003, 1252:363-372.
45. O'Banion M.K. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999, 13:45-82.
46. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007, 21:9-19.
47. Pothion S., Bizot J.C., Trovero F., Belzung C. Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 2004, 155:135-146.
48. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003, 160:1554-1565.
49. Seibert K., Masferrer J., Zhang Y., Gregory S., Olson G., Hauser S., et al. Mediation of inflammation by cyclooxygenase-2. Agents Actions Suppl 1995, 46:41-50.
50. Tocco G., Freire-Moar J., Schreiber S.S., Sakhi S.H., Aisen P.S., Pasinetti G.M. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp Neurol 1997, 144:339-349.
51. Tu X.K., Yang W.Z., Shi S.S., Wang C.H., Chen C.M. Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia. Neurochem Res 2009, 34:1626-1634.
52. Tu X.K., Yang W.Z., Shi S.S., Chen Y., Wang C.H., Chen C.M., et al. Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation 2011, 34:463-470.
53. Wang X.K., Zhang L.J., Hua L., Xing D.M., Du L.J. Effect of flavonoids in Scutellariae Radix on depression-Like behavior and brain rewards: possible in dopamine system. Tsinghua Sci Technol 2010, 15:460-466.
54. Wang Y., Yang F., Liu Y.F., Gao F., Jiang W. Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats. Neurosci Lett 2011, 499:74-79.
55. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997, 134:319-329.
56. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 1987, 93:358-364.
57. Zhang Y., Gu F., Chen J., Dong W. Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Res 2010, 1366:141-148.